ARQT: Matsuda Masaru discloses a sale

By AlphaYouPublished Sep 23, 2026Form 4

Stocks in this disclosure

Reported activity

Matsuda Masaru

Reporting filer

Matsuda Masaru reported Sale in Arcutis Biotherapeutics, Inc.: 3674 units of Common Stock, dated 2026-09-16. The full Form 4 contains 1 transaction entry.

Disclosed: Sep 18, 2026

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Common Stock	Matsuda Masaru	2026-09-16	S	Sale	3674	25.0009	112,508	2 days	Filed terms security Title: Common Stock transaction Date: 2026-09-16 transaction Form Type: 4 transaction Code: S equity Swap Involved: 0 id: F1 transaction Shares: 3674 transaction Price Per Share: 25.0009 id: F2 transaction Acquired Disposed Code: D shares Owned Following Transaction: 112508 direct Or Indirect Ownership: D

Common Stock

Owner: Matsuda Masaru
Date: 2026-09-16
Code: S
Action: Sale
Quantity: 3674
Price: 25.0009
Following holdings: 112,508
Reporting delay: 2 days
Filed terms and references: Filed terms
security Title: Common Stock
transaction Date: 2026-09-16
transaction Form Type: 4
transaction Code: S
equity Swap Involved: 0
id: F1
transaction Shares: 3674
transaction Price Per Share: 25.0009
id: F2
transaction Acquired Disposed Code: D
shares Owned Following Transaction: 112508
direct Or Indirect Ownership: D

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
Matsuda Masaru: See Remarks.
The filing reports a Rule 10b5-1 trading plan.
F1: The transactions reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on June 5, 2026, by the Reporting Person, with a plan end date of September 1, 2027.
F2: The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.01, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Original sources

SEC ownership filing

Prepared automatically from public filing data. Report a correction.

Security

Owner

Date

Code

Action

Quantity

Price

Following holdings

Reporting delay

Filed terms and references

Common Stock

Matsuda Masaru

2026-09-16

Sale

3674

25.0009

112,508

2 days

Filed terms

security Title: Common Stock
transaction Date: 2026-09-16
transaction Form Type: 4
transaction Code: S
equity Swap Involved: 0
id: F1
transaction Shares: 3674
transaction Price Per Share: 25.0009
id: F2
transaction Acquired Disposed Code: D
shares Owned Following Transaction: 112508
direct Or Indirect Ownership: D

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.

Matsuda Masaru: See Remarks.

The filing reports a Rule 10b5-1 trading plan.

F1: The transactions reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on June 5, 2026, by the Reporting Person, with a plan end date of September 1, 2027.

F2: The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.01, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.